Sahu S, Ganguly R, Raman P. Leptin augments recruitment of IRF-1 and CREB to thrombospondin-1 gene promoter in vascular smooth muscle cells in vitro. Am J Physiol Cell Physiol 311: C212-C224, 2016. First published June 8, 2016 doi:10.1152/ajpcell.00068.2016.-We previously reported that high pathophysiological concentrations of leptin, the adipocyte-secreted peptide, upregulate the expression of a potent proatherogenic matricellular protein, thrombospondin-1 (TSP-1), in vascular smooth muscle cells. Moreover, this regulation was found to occur at the level of transcription; however, the underlying molecular mechanisms remain unknown. The goal of the present study was to investigate the specific transcriptional mechanisms that mediate upregulation of TSP-1 expression by leptin. Primary human aortic smooth muscle cell cultures were transiently transfected with different TSP-1 gene (THBS1) promoter-linked luciferase reporter constructs, and luciferase activity in response to leptin (100 ng/ml) was assessed. We identified a long THBS1 promoter (Ϫ1270/ϩ750) fragment with specific leptin response elements that are required for increased TSP-1 transcription by leptin. Promoter analyses, protein/DNA array and gel shift assays demonstrated activation and association of transcription factors, interferon regulatory factor-1 (IRF-1) and cAMP response element-binding protein (CREB), to the distal fragment of the THBS1 promoter in response to leptin. Supershift, chromatin immunoprecipitation, and coimmunoprecipitation assays revealed formation of a single complex between IRF-1 and CREB in response to leptin; importantly, recruitment of this complex to the THBS1 promoter mediated leptin-induced TSP-1 transcription. Finally, binding sequence decoy oligomer and site-directed mutagenesis revealed that regulatory elements for both IRF-1 (Ϫ1019 to Ϫ1016) and CREB (Ϫ1198 to Ϫ1195), specific to the distal THBS1 promoter, were required for leptin-induced TSP-1 transcription. Taken together, these findings demonstrate that leptin promotes a cooperative association between IRF-1 and CREB on the THBS1 promoter driving TSP-1 transcription in vascular smooth muscle cells.
thrombospondin-1; vascular smooth muscle cells; leptin; interferon regulatory factor-1; cAMP response element-binding protein; transcription HYPERLEPTINEMIA, or elevated leptin levels, independent of inflammatory and metabolic abnormalities, is an important risk factor for development of macrovascular complications associated with diabetes and obesity. Accumulating evidence indicates that the 16-kDa adipocyte-secreted peptide leptin is a putative pathophysiological trigger for atherosclerosis (3, 10) . Numerous in vitro and in vivo studies have shown that leptin exerts several proatherogenic effects, including increased migration and proliferation of vascular smooth muscle cells (VSMCs), endothelial cell dysfunction, vascular calcification, and enhanced platelet aggregation (17, 19, 24, 25, 36, 43) . Leptin produces its biological response via interaction with its receptor found on different vascular cell types, and this interaction is regarded as the first step in leptin-induced atheroma formation (16, 25, 26) . Previous studies have shown that leptin modulates the expression of several vascular genes associated with atherosclerosis and abnormal angiogenesis, including cytokines, growth factors, and extracellular matrix proteins (12, 18, 19, 26, 28, 30, 41) . Earlier findings from our laboratory demonstrated that leptin, at pathophysiological hyperleptinemic concentrations, upregulates the expression of a matricellular protein, thrombospondin-1 (TSP-1), in human and mouse aortic smooth muscle cells (8) .
TSP-1 is an important proatherogenic and antiangiogenic protein that controls cell-cell and cell-matrix interactions (1, 5) . GeneQuest studies reported an association between specific single-nucleotide polymorphisms in the TSP family of genes and both coronary artery disease and myocardial infarction, providing a basis for linking TSP-1 to atherosclerotic vascular disease (35, 37) . TSP-1 expression is significantly increased in injured vascular walls and early-stage atherosclerotic lesions (31) (32) (33) . Earlier work demonstrated that TSP-1, identified among a cluster of immediate early genes and growth factor genes, activates VSMC growth (20, 22) , contributing to its proatherogenic properties. Multiple cell types, including endothelial cells, VSMCs, fibroblasts, mesangial cells, and retinal pigment epithelial cells, can secrete TSP-1, and this secretion is controlled in a tissue-specific manner (4, 29, 39) . Moreover, we and others reported differential regulatory mechanisms of TSP-1 gene transcription, dependent on cell-selective activation and binding of diverse transcription factors (TFs) to the TSP-1 gene promoter (9, 29) .
We previously reported that leptin upregulates TSP-1 expression in human aortic smooth muscle cells (HASMCs) in vitro and that this upregulation occurs at the level of transcription (8) . We also showed that leptin-induced increase in TSP-1 mRNA and protein expression was mediated via Janus-associated kinase-2 (JAK-2)-and mitogenactivated protein kinase (MAPK)-dependent signaling cascades (8) . In the present study we aimed to elucidate the underlying molecular mechanisms by which leptin increases TSP-1 transcription. Our results demonstrate that leptin augments activation and assembly of a single transcriptional complex between the nuclear proteins interferon regulatory factor-1 (IRF-1) and cAMP response element-binding protein (CREB) on the TSP-1 gene (THBS1) promoter. In addition, we found that both IRF-1-and CREB-binding regulatory elements are required for leptin-induced TSP-1 transcription in VSMCs.
MATERIALS AND METHODS
Reagents and antibodies. Primary HASMC cultures (catalog no. C-007-5C, lot no. 200707-934) were purchased from Cascade Biologics; recombinant human leptin (Ͻ1.0 endotoxin unit/g protein) from Peprotech; Dulbecco's modified Eagle's medium-nutrient mixture F12 (DMEM/F12) from Thermo Fisher; fetal bovine serum (FBS) and penicillin-streptomycin solution from Atlanta Biologicals and Cellgro, respectively; Lipofectin reagent from Invitrogen; and nuclear extraction and electrophoretic mobility shift assay (EMSA) kits from Cayman Chemicals and Panomics, respectively. Polyclonal antibodies against IRF-1 (catalog no. sc-497) and CREB (catalog no. sc-186) were purchased from Santa Cruz Biotechnology; antibody against signal transducer and activator of transcription (Stat)-1 (catalog no. 610185) from BD Biosciences; monoclonal antibodies against CREB (catalog no. 9197) and IRF-1 (catalog no. 8478), as well as anti-Stat-3 (catalog no. 4904) and anti-JAK-2 (catalog no. 3230), from Cell Signaling Technology; and anti-luciferase (catalog no. G7451) from Promega. TranSignal protein/DNA combo array, QuikChange Lightning site-directed mutagenesis kit, and ChIP-IT Express kit were purchased from Panomics, Agilent Technologies, and Active Motif, respectively.
Cell culture, transient transfection, and plasmids. Primary HASMC cultures between passages 6 and 13 were grown in complete DMEM/F12 medium supplemented with 10% FBS and 1% penicillinstreptomycin. The same batch of cells at different passages was used in all experiments, and the contractile phenotype of confluent HASMCs was confirmed by positive ␣-actin staining. About 70 -80% confluent HASMCs were transiently transfected with pGL3-basic vector control or different THBS1 promoter fragments linked to the luciferase reporter gene construct using Lipofectin reagent, as reported elsewhere (8) . The transfection efficiency of primary HASMC cultures, as indicated by the supplier, as well as our unpublished observations, under the experimental conditions utilized was ϳ30 -40%. Moreover, cell passage affected transfection efficiency: a marked decline was noted at passage 14 and above. Transfected cells were incubated with or without 100 ng/ml leptin for different durations; luciferase activity was measured and normalized to total cell protein content. The different plasmids containing human THBS1 promoter or its deleted fragments (p Ϫ1270/ϩ750, p Ϫ370/ϩ750, and p Ϫ280/ϩ750) cloned into the promoterless pGL3-basic luciferase reporter vector (Promega) were a kind gift from Dr. Olga Stenina Adognravi (Cleveland Clinic).
Cell treatment and nuclear extraction. Confluent HASMCs were placed in low-glucose (5 mM) DMEM containing 0.2% FBS at ϳ24 h prior to initiation of treatments. Cells were incubated with or without 100 ng/ml leptin for 3 h. A nuclear extraction kit (Cayman Chemicals) was used according to the manufacturer's instructions to prepare nuclear extracts from control (untreated) and leptin-treated HASMCs; protein concentrations in the nuclear extracts were determined using the Bio-Rad protein assay.
Protein/DNA array. Activation of TFs in leptin-stimulated HASMC cultures was detected using the TranSignal protein/DNA combo array (Panomics) according to the manufacturer's instructions. Briefly, equal amounts of nuclear extracts prepared from control (untreated) and leptin-stimulated cells were preincubated with a set of biotin-labeled DNA-binding oligonucleotide probes (provided by the supplier). The resulting protein-DNA complex was then separated from the free DNA probe and allowed to hybridize with the array membranes spotted with different consensus DNA-binding sequences, provided by the manufacturer. Signals were detected using streptavidin-horseradish peroxidase, and membranes were exposed to autoradiographs for varying lengths of time. To determine the signal intensities representing the corresponding DNA-binding activity of TFs, each spot on the array membranes was quantified using ImageJ software. Each experiment was repeated twice using two different sets of HASMC cultures. In each individual experiment, triplicate sets of wells were treated with or without leptin, and nuclear extracts pooled from these wells were utilized in the protein/DNA array. Results are expressed as fold increase vs. control (untreated cells).
EMSA. Nuclear extracts from control and leptin-stimulated HASMCs were used in nonradioactive EMSA, as we reported elsewhere (29) . Briefly, 6 g of nuclear extracts were incubated at room temperature for 30 min with biotinylated oligonucleotide consensus probes specific for ␥-activation site/interferon-stimulated response element (GAS/ISRE) and CREB (Panomics). In parallel experiments, nuclear extracts were incubated with THBS1 promoter-specific biotinylated oligonucleotide probes with putative binding sequences for IRF-1 and CREB or related mutant probes. To determine specificity of the DNA-binding activity, incubations were continued in the presence or absence of 66-fold molar excess of unlabeled cold oligonucleotide probes. For EMSA/supershift assay, nuclear extracts were preincubated with 1 g each of different antibodies (anti-IRF-1, anti-Stat-1, anti-Stat-3, anti-JAK-2, or anti-CREB) or nonspecific antibody (antiluciferase) for 30 min on ice prior to addition of biotin-labeled oligonucleotide probes. The sequences of THBS1 promoter-specific probes with core sequences for IRF-1-and CREB-binding sites (underlined) were as follows: 5=-AGGAGCCGAAAAATGAAA-GAACGTTTAGG for IRF-1 and 5=-GGAGCGAGGCGGCT-GACGTCCCATCCCGA for CREB. Samples were subjected to electrophoretic separation (120 V for 1 h at 4°C) in 6% polyacrylamide gel and blotted on a GeneScreen Plus nylon membrane (4°C at 300 mA for 30 -45 min) followed by chemiluminescence detection using autoradiography films exposed for 1 s to 15 min.
Coimmunoprecipitation and immunoblotting. Whole cell lysates were prepared from control and leptin-treated HASMCs, and protein concentrations were determined as reported elsewhere (8) . Samples were subjected to coimmunoprecipitation assay. Briefly, 1 mg of total cell extract was immunoprecipitated by incubation with 1 g of rabbit anti-IRF-1 or anti-CREB (Santa Cruz Biotechnology) polyclonal antibodies and protein G-coated magnetic beads overnight at 4°C; concurrently, leptin-treated cell extracts were immunoprecipitated with rabbit IgG or no antibody, which served as negative controls. The resulting samples were resolved using SDS-PAGE, transferred to polyvinylidene difluoride membranes, and then sequentially immunoblotted with different antibodies: anti-IRF-1 (Cell Signaling Technology), anti-CREB (Cell Signaling Technology), anti-Stat-3 (Cell Signaling Technology), and anti-Stat-1 (BD Biosciences); immunoreactive signals were visualized using chemiluminescence detection reagents. In each case, membranes were also stained with Ponceau S to confirm equal protein loading.
Chromatin immunoprecipitation. Confluent HASMCs were treated with or without 100 ng/ml leptin for 3 h, and chromatin was prepared according to the manufacturer's instructions. The quality of chromatin was monitored using the control kit (Active Motif) supplied with positive and negative antibodies and primers. Chromatin derived from control and leptin-treated cells was used in the chromatin immunoprecipitation (ChIP) assay using ChIP-IT Express kit (Active Motif), as we previously reported (29) . Briefly, parallel ChIP reactions were set up using anti-IRF-1 and anti-CREB antibodies as well as for input DNA processing. Additional ChIP reactions were also set up using GAPDH primers as controls. The coprecipitated DNA of the THBS1 promoter-specific leptin response elements was amplified by PCR using the following primer sequences: 5=CAATGACAGAAGCAC-TAGGCAGCGCACTCATGGC (forward) and 5=GGAGAAT-TTGCAGAACCATCTGGCTCCAGAGTCTTCAGC (reverse) for THBS1-IRF-1 and 5=CCTATGCCCTGGCCTCGGAGCGAGC-CCGATAGCGC (forward) and 5=GCCGCTGCCTAGTGCTTCTGT-CATTGAAGTCTGGTCTCC (reverse) for THBS1-CREB. ImageJ software was used for densitometric quantification of all PCR blots.
Transient transfection with decoy and mutant oligomers. Based on the sequences of IRF-1-and CREB-binding motifs on the THBS1 promoter, sense and antisense strands of IRF-1-and CREB-binding decoy and corresponding mismatched mutant oligonucleotides were designed and purchased from IDT. Annealing of sense and antisense strands of the oligonucleotides was carried out in the presence of the annealing buffer by heating at 95°C for 5 min, followed by a steady temperature drop to room temperature. About 70 -80% confluent HASMC cultures were transiently cotransfected with IRF-1-and CREB-binding decoy or corresponding mismatched mutant oligomers together with the Ϫ1270/ϩ750 pTHBS1 promoter fragment or pGL3-basic control vector using Lipofectin reagent, as reported elsewhere (8) . Transfected cells were incubated with or without 100 ng/ml leptin; luciferase activity was measured in cell extracts 48 h later and normalized to total cell protein content. The specific sequences of the decoy and mutant oligomers were as follows: 5=-AAAATGAAAA-GAACG-3= (decoy) and 5=-AAAATGCCAAGAACG-3= (mutant) for IRF-1 and 5=-GGCGGCTGACGTCCC-3= (decoy) and 5=-GGCG-GCTCCCGTCCC-3= (mutant) for CREB. The core sequences of specific binding sites are underlined; the sites of mutation are shown in bold.
Site-directed mutagenesis and cell transfection. The QuikChange site-directed mutagenesis kit (Agilent Technologies) was used to mutate putative IRF-1-and CREB-binding sites on the Ϫ1270/ϩ750 THBS1 promoter linked-luciferase reporter construct according to the manufacturer's instructions. Primer sequences used to generate the specific mutations were as follows: 5=-GGAGCCGAAAAATGCCAAGAACGTT-TAGGGAGGAAAAAG-3= (sense) and 5=-CTTTTTCCTCCCTA-AACGTTCTTGGCATTTTTCGGCTCC-3= (antisense) for the IRF-1 mutant and 5=-GGAGCGAGGCGGCTCCCGTCCCATCCCGA-3= (sense) and 5=-TCGGGATGGGACGGGAGCCGCCTCGCTCC-3= (antisense) for the CREB mutant. The specific binding sites are underlined; the sites of mutation are shown in bold. Prior to use of these mutagenic primers, mutagenesis PCRs were set up using the Ϫ1270/ϩ750 THBS1 promoter as the template. Parallel reactions were set up using pBlueScript II SK(Ϫ) phage plasmid (supplied with the kit) as the mutagenesis control. PCR-amplified products were then treated with DpnI restriction endonuclease enzyme for removal of the parental methylated DNAs. This was followed by transformation into XL10-Gold ultracompetent cells (supplied with the kit). Concurrently, pUC 18 vector was used as the transformation control. The transformed cells were plated onto ampicillin-containing agar plates coated with X-gal/isopropyl ␤-D-1-thiogalactopyranoside (Amresco) for blue/white screening. Blue colonies were positive for pBlueScript mutagenesis on the control plate, and white colonies on the IRF-1 and CREB mutagenesis plates were positive for mutagenesis. Discreet colonies were selected and grown in ampicillin-containing Luria broth. Plasmids were purified, and the resulting mutant plasmids were verified by sequencing. About 70 -80% confluent primary HASMC cultures were transiently transfected with IRF-1 mutant, CREB mutant, or wildtype Ϫ1270/ϩ750 THBS1 promoter-luciferase reporter constructs using Lipofectin reagent. Transfected cells were incubated with or without 100 ng/ml leptin, and luciferase activity was measured 48 h later (8) . Cell extracts were used for protein estimation using bicinchoninic acid protein assay, and luciferase activity was normalized to total protein content in cell extracts.
Statistical analysis. Each experiment was repeated at least three times, with three to six replicates for each treatment group in individual experiments. For luciferase reporter assays, each experiment was repeated three to four times, with three to six wells for each treatment group used in individual experiments. Densitometric quantifications of immunoblots and EMSA blots were performed using ImageJ software. Values are means Ϯ SE; n is the number of independent experiments. Significant differences between means were detected using unpaired Student's t-test; P Յ 0.05 was considered statistically significant.
RESULTS

THBS1 promoter fragment maximally responsive to leptin in
HASMCs. We reported elsewhere that high leptin (100 ng/ml) stimulates TSP-1 mRNA and protein expression in HASMCs, with the maximal response observed following 3 h of incubation. In the present study we first evaluated a dose-dependent effect of leptin on the THBS1 promoter, previously shown to be leptin-responsive (8) . Primary HASMC cultures were transiently transfected with the Ϫ1270/ϩ750 THBS1 promoterlinked luciferase reporter gene construct and then stimulated with 1-100 ng/ml leptin. Our results indicate that HASMC incubation with 100 ng/ml leptin increased THBS1 promoter activity (P Ͻ 0.0001) compared with untreated cells, while lower concentrations of leptin did not have an effect; in contrast, cells transfected with pGL3-basic vector control remained unaffected by all leptin concentrations tested (Fig. 1A) . Next, to determine whether leptin induces a time-dependent response in THBS1 promoter activity, cells transfected with the Ϫ1270/ϩ750 THBS1 promoter-luciferase reporter gene construct were incubated with 100 ng/ml leptin for 1-48 h. As shown in Fig. 1B , leptin significantly increased the luciferase activity of the THBS1 promoter as early as 3 h of incubation (ϳ50%), with the maximal response attained 48 h after leptin stimulation. Given that the luciferase reporter driven by the THBS1 promoter showed the highest response at 48 h of leptin stimulation, all subsequent experiments involving luciferase reporter assays using transfected cells were performed at 48 h. Furthermore, to determine the THBS1 promoter region that is most responsive to leptin, primary HASMC cultures were transiently transfected with different THBS1 promoter deletion constructs driving expression of the luciferase reporter gene and then stimulated with or without 100 ng/ml leptin. Luciferase activity was then measured to identify the specific promoter region responsible for leptin-induced upregulation of TSP-1 gene transcription. In the present study a Ϫ1270/ϩ750 THBS1 promoter fragment was identified to be maximally responsive to leptin. Specifically, leptin treatment resulted in a robust 2.9-fold increase in luciferase activity in cells transfected with the Ϫ1270/ϩ750 THBS1 promoter, while it had no effect on cells transfected with shorter (Ϫ370/ϩ750 and Ϫ280/ ϩ750) THBS1 promoter fragments (Fig. 1C) . Together, these data clearly demonstrate that leptin-induced upregulation of TSP-1 transcription is dependent on a distal THBS1 promoter region, relative to the transcriptional start site.
TFs directly activated by leptin in HASMCs. Based on our earlier reports that the endogenous TSP-1 gene is activated in HASMCs at the level of transcription following 3 h of leptin incubation, this time point was utilized in the current study to delineate the transcriptional mechanism underlying endogenous TSP-1 gene expression induced by leptin. To determine putative binding sites for TFs in the leptin-responsive fragment of the TSP-1 promoter, the Ϫ1270/ϩ750 THBS1 promoter was analyzed using the MatInspector program (Genomatix) (6) . Based on this analysis, predicted binding sites for several TFs located close to the Ϫ1270 site, including CREB-and GAS/ISRE-binding proteins such as IRF-1 and Stat-1/3, were identified (Fig. 1D) . Next, a targeted proteomics approach was used to identify a group of TFs that were activated following leptin stimulation. Briefly, nuclear extracts from control (untreated) and leptin-treated HASMCs were subjected to TranSignal protein/DNA combo array, which specifically identifies the DNA-binding activity of only activated TFs binding to their corresponding consensus DNA-binding sequences. Among these were the GAS, ISRE, and activating TF/cAMP-response element (ATF/CRE) (Fig. 1E) . Densitometric quantification of the array signal intensities revealed a significant increase (Ͼ2.0-fold) in the binding activity of GAS, ISRE, and ATF/ CRE regulatory elements in leptin-stimulated HASMCs compared with untreated cells (Fig. 1F) . These regulatory motifs were located in the leptin-responsive distal THBS1 promoter fragment close to the Ϫ1270 site (between Ϫ1025 and Ϫ1198). Together, these results demonstrate a direct activation of nuclear proteins, binding to leptin-responsive regulatory elements specific to the distal THBS1 promoter fragment.
Leptin augments IRF-1-and CREB-binding activity to THBS1 promoter in HASMCs. To confirm the roles of GAS/ ISRE-and CREB-binding motifs in leptin-induced upregulation of TSP-1 transcription, nuclear extracts from control and leptin-treated HASMCs were subjected to EMSA using GAS/ A: primary HASMC cultures were transiently transfected with the Ϫ1270/ϩ750 THBS1 promoter linked to the luciferase reporter gene construct or pGL3-basic vector control and then incubated with or without 1-100 ng/ml leptin for 48 h. B: HASMCs transfected with the Ϫ1270/ϩ750 THBS1 promoter-luciferase reporter construct were incubated with or without 100 ng/ml leptin for 1-48 h. Luciferase activity was measured at the end point. Values are means Ϯ SE of 3 independent experiments, with 3-6 replicates for each treatment group within an independent experiment. C: primary HASMC cultures were transiently transfected with pGL3-basic vector control or different THBS1 promoter deletion fragments (Ϫ1270/ϩ750, Ϫ370/ϩ750, or Ϫ280/ϩ750) linked to the luciferase reporter gene and then incubated with or without 100 ng/ml leptin. Luciferase activity was measured 48 h later. Values are means Ϯ SE of 5 independent experiments compared with untreated controls. *P Յ 0.05 vs. control (Ϫ1270/ϩ750 THBS1). D: MatInspector (version 7.4.3, Genomatix) analysis of the putative leptin-responsive binding sites in the Ϫ1270/ϩ750 THBS1 promoter fragment. Shown in bold are transcription factors binding to the ␥-activation site (GAS)-, interferonstimulated response element (ISRE)-, and activating transcription factor/cAMP response element (ATF/CRE)-binding elements on the THBS1 promoter. AhR, aryl hydrocarbon receptor; CREB, cAMP response element-binding protein; HIF-1, hypoxia-inducible factor-1; IRF-1, interferon regulatory factor-1; PPAR, peroxisome proliferator-activated receptor; SP-1, specificity protein-1; Stat, signal transducer and activator of transcription; USF, upstream stimulatory factor. E and F: direct activation of transcription factors by leptin. Nuclear extracts from HASMCs treated with or without 100 ng/ml leptin for 3 h were subjected to TranSignal protein/DNA combo array. E: representative protein/DNA array. F: densitometric quantification of signal intensities depicting transcription factor activity. Experiment was repeated twice using 2 different isolates of HASMC cultures and 2 independent sets of array membranes. In each individual experiment, a triplicate set of wells were treated with or without leptin, and nuclear extracts pooled from these wells were used in the protein/DNA array. Values are means Ϯ SE. *P Յ 0.05 vs. control.
ISRE (a common cis-binding element for IRF and Stat proteins)-and CREB-specific consensus oligonucleotide probes (Panomics). Leptin increased GAS/ISRE-and CREB-binding activity, while the resulting protein-DNA complex was dramatically abrogated by 66-fold molar excess of unlabeled probes, validating specificity of the DNA-binding complex (P Յ 0.0002; Fig. 2, A and B) . Interestingly, while the core sequence for the CREB-binding site (CTGACGTC) within the C THBS1-IRF-1 labeled oligo 66X cold oligo labeled mutant oligo THBS1 promoter aligned with that of the corresponding CREB consensus probe (provided by Panomics), the sequence for the THBS1 promoter-specific IRF-1-binding site did not completely align with that of the GAS/ISRE consensus probe; however, both the GAS/ISRE consensus and THBS1 promoter-specific IRF-1 probes contained a sequence (GTTT) common to ISRE and GAS elements. To specifically delineate whether IRF-1 and CREB are involved in leptin-induced TSP-1 transcription, additional EMSA was performed using biotinylated THBS1 promoter-specific IRF-1-and CREBbinding oligonucleotide probes. In each case, formation of a distinct nucleoprotein complex depicting IRF-1 and CREB activation by leptin vs. untreated control was observed (Fig. 2,  C and D, lane 2) . In contrast, IRF-1-and CREB-binding activity remained unaffected when nuclear extracts derived from leptin-treated cells were incubated with corresponding biotin-labeled mutant oligonucleotide probes, confirming specificity of the observed bands (Fig. 2, C and D, lane 5) . Specificity of the DNA-binding complex was also verified using biotin-labeled probes in combination with 66-fold molar excess of unlabeled probes, revealing a marked attenuation of IRF-1-and CREB-binding activity to the THBS1 promoter in leptin-treated cells (Fig. 2 
, C and D, lane 3 vs. lane 2).
Additionally, these results were verified by EMSA/supershift assay; specifically, preincubation of nuclear extracts from leptin-treated cells with anti-IRF-1 or anti-CREB antibody followed by incubation with biotinylated THBS1 promoter-specific IRF-1 or CREB probes inhibited formation of the corresponding protein-DNA complex (Fig. 2 , C and D, lane 4 vs. samples incubated with biotinylated probes alone). Together, these data clearly demonstrate that leptin augments IRF-1 and CREB DNA-binding activity to the THBS1 promoter in HASMCs in vitro.
Leptin promotes formation and recruitment of a single transcriptional complex between IRF-1 and CREB on the THBS1 promoter.
To characterize the interaction between IRF-1 and CREB in leptin-induced upregulation of TSP-1 transcription, EMSA/supershift assay was performed using promoter-specific biotinylated probes corresponding to IRF-1-and CREB-binding motifs in combination with corresponding antibodies. Both anti-IRF-1 and anti-CREB antibodies remarkably inhibited formation of the CREB and IRF-1 nucleoprotein complex on the THBS1 promoter, respectively, in leptin-treated cells. In contrast, an unrelated antibody (anti-luciferase), used as a negative control, did not have an effect on the protein-DNA complex formed on the THBS1 promoter in response to leptin. Furthermore, incubation with anti-Stat-1, anti-Stat-3, and anti-JAK-2 antibodies significantly impaired recruitment of the complex to both the IRF-1-and CREB-specific probes, corresponding to the THBS1 promoter (Fig. 3, A and B) . Densitometric quantification of EMSA blots revealed a significant increase in both IRF-1 (P Ͻ 0.02; Fig. 3B ) and CREB (P Ͻ 0.02; Fig.  3D ) nucleoprotein complex formed on the THBS1 promoter in response to leptin. In contrast, formation of this nucleoprotein complex was attenuated (P Ͻ 0.05) by different antibodies. Next, a direct association between IRF-1 and CREB in response to leptin was assessed using coimmunoprecipitation and immunoblotting experiments. Consistent with the supershift assay data, both CREB and IRF-1 were immunoprecipitated from leptin-treated extracts using anti-IRF-1 and anti-CREB antibodies, respectively (Fig. 4A,  top) . Densitometric quantification of immunoblots depicted a significant increase (30 -50%) in both CREB and IRF-1 protein expression, forming a single complex in response to leptin (vs. untreated controls, Fig. 4B ). In addition, immunoprecipitated IRF-1 pulled down Stat-3 proteins in the complex, revealing a 77% increase in Stat-3 expression in leptin-treated HASMCs compared with untreated cells. In contrast, immunoprecipitated CREB failed to physically associate with Stat-3 proteins in leptin-treated cells compared with untreated controls (Fig. 4A, middle, and Fig. 4B ). To confirm specificity of the coimmunoprecipitation data, leptin-treated cell extracts were concurrently incubated with IgG control antibody or no primary antibody and then immunoblotted with anti-IRF-1 or anti-CREB antibody. In each case, the ability to precipitate IRF-1 and CREB proteins was markedly blunted compared with immunoprecipitation with anti-IRF-1 and anti-CREB antibodies (Fig. 4A,  bottom) , confirming specificity of the immunoprecipitation reactions. Interestingly, neither IRF-1 nor CREB directly interacted with Stat-1 proteins in leptin-treated cells (data not shown).
Assembly of the transcriptional complex formed between IRF-1 and CREB on the THBS1 promoter in response to leptin was further investigated using ChIP assay. Briefly, IRF-1 and CREB antibodies were used to immunoprecipitate formaldehyde cross-linked protein-chromatin complexes from leptin-treated or control (untreated) cells. The resulting immunoprecipitated DNA was then analyzed by PCR using primers specifically amplifying regions corresponding to the predicted IRF-1-or CREB-binding motifs in the THBS1 promoter. Parallel reactions were also set up using GAPDH primers as controls. Leptin enhanced recruitment of both IRF-1 and CREB on the THBS1 promoter compared with untreated HASMCs (Fig. 5, A-D) . On the other hand, anti-IgG, used as a negative control, failed to precipitate IRF-1-or CREB-binding promoter fragments from control and leptin-treated HASMC chromatin. Notably, anti-IRF-1 and anti-CREB ChIP antibodies precipitated Fig. 2 . Leptin augments IRF-1-and CREB-binding activity to the THBS1 promoter in HASMCs. After incubation in low-glucose (5 mM) medium containing 0.2% FBS for 24 h, HASMC cultures were treated with or without 100 ng/ml leptin for 3 h. Nuclear extracts were prepared and subjected to electrophoretic mobility shift assay (EMSA). Control and leptin-treated HASMC nuclear extracts (6 g) were incubated at room temperature for 30 min with biotinylated oligonucleotide consensus probes (Panomics) specific for GAS/ISRE (A), CREB (B), and biotin-labeled THBS1 promoter-specific IRF-1 (C) and CREB (D) oligonucleotide probes. In each case, to confirm specificity of the DNA-binding complex, parallel reactions were set up in the presence of 66-fold molar excess of the corresponding unlabeled probes. Additional reactions were set up using biotin-labeled THBS1 promoter-specific mutant IRF-1 and CREB probes (C and D). In each case, black arrows indicate the corresponding protein-DNA complexes formed. Top: representative EMSA blots from 5 independent experiments. Bottom: summary data depicting densitometric quantification of EMSA blots. Values are means Ϯ SE of 5 independent EMSA experiments compared with untreated controls. *P Յ 0.05 vs. controls; †P Յ 0.02 vs. leptin (labeled oligonucleotide).
both IRF-1 and CREB regulatory elements from the THBS1 promoter in response to leptin (Fig. 5, A and C) . Quantification of PCR blots demonstrated a significant increase (Ն2-fold) in IRF-1 and CREB recruitment to putative IRF-1-binding motifs on the THBS1 promoter in leptin-treated HASMCs compared with untreated cells (Fig. 5B) . Similarly, there was a ϳ2.3-fold increase in both IRF-1 and CREB association with THBS1 promoter-specific CREB regulatory element in response to leptin (Fig. 5D ) compared with untreated cells. Contrary to these data, leptin failed to recruit IRF-1 or CREB on the GAPDH promoter, used as a control (Fig. 5, E and F) . Together, these results clearly demonstrate that leptin promotes recruitment of a single transcriptional complex formed between the nuclear proteins IRF-1 and CREB on the THBS1 promoter in VSMCs.
Both IRF-1-and CREB-binding motifs are required for leptin-induced TSP-1 transcription. To determine whether specific IRF-1-and CREB-binding elements were required for upregulation of TSP-1 transcription by leptin, HASMCs were cotransfected with IRF-1-or CREB-binding decoy oligonucleotides together with the Ϫ1270/ϩ750 THBS1 promoter-luciferase reporter construct and then incubated with or without leptin, and luciferase activity was measured at the end point. The decoy oligomers were used in a large molar excess compared with the promoter; in parallel cell transfections, molar excess of mutant IRF-1-and CREB-binding oligomers was used together with the Ϫ1270/ϩ750 THBS1 promoter construct. Leptin significantly decreased THBS1 promoter activity in cells cotransfected with the decoy sequences compared with cells cotransfected with mutant oligomers. Specifically, THBS1 promoter activity was enhanced by 2.1-to 2.5-fold in HASMCs cotransfected with mutant oligomers stimulated with leptin compared with untreated controls. In contrast, leptininduced promoter activity was completely abrogated in cells transfected with decoy oligomers (Ն50% vs. leptin-treated cells transfected with mutant oligomers; Fig. 6, A and B) . As expected, TSP-1 promoter activity remained unaffected in HASMCs cotransfected with pGL3-basic control vector. To further assess the functional importance of IRF-1-and CREBbinding elements in leptin-induced TSP-1 transcription, sitedirected mutagenesis was performed. Specific point mutations were introduced in IRF-1-or CREB-binding sites in the leptinresponsive Ϫ1270/ϩ750 THBS1 promoter fragment, and cells were transiently transfected with these mutant plasmids. As illustrated in Fig. 6C , mutations in IRF-1-and CREB-binding motifs completely blocked (by ϳ50%) THBS1 promoter activation by leptin compared with cells transfected with the wild-type THBS1 promoter construct. Together, these results clearly demonstrate that both IRF-1-and CREB-binding regulatory elements are required for upregulation of TSP-1 transcription by leptin in HASMCs in vitro.
DISCUSSION
Previous studies from our laboratory demonstrated that pathophysiological concentrations of leptin, mimicking hyperleptinemia, upregulate TSP-1 mRNA and protein expression in VSMCs. Moreover, this leptin-induced increase in TSP-1 expression was reported to be controlled at the level of transcription (8) . The purpose of the present study was to delineate the specific molecular mechanism by which leptin increases TSP-1 transcription. Specifically, we demonstrated that leptin promotes activation and recruitment of a single transcriptional complex between the nuclear proteins IRF-1 and CREB on the THBS1 promoter in VSMCs. In addition, we have shown that both IRF-1-and CREB-binding regulatory elements are essential for upregulation of TSP-1 transcription by leptin.
While high glucose has been reported to activate the THBS1 promoter (29, 39) , the current study demonstrated, for the first time, a leptin-specific molecular mechanism underlying THBS1 induction. We previously revealed a cell-specific differential mechanism of TSP-1 transcription by high glucose in vitro (29) ; specifically, the long promoter region (Ϫ1270) was required for increased TSP-1 transcription in VSMCs, whereas a glucose-responsive shorter promoter area (Ϫ280) specific for endothelial cells was identified (9) . Similar findings have been reported for other cell types, including mesangial cells and pericytes (39) , suggesting a glucose-specific THBS1 promoter response. The present study identified a long THBS1 promoter fragment requisite for TSP-1 transcription induced by leptin in VSMCs. These results suggest the presence of distinct leptin response elements only in the longer THBS1 promoter region that were completely absent in shorter promoter fragments.
MatInspector analysis of the leptin-responsive THBS1 promoter revealed putative binding elements located close to the Ϫ1270 site on the distal end of the promoter; many of these were similar to the smooth muscle cell-specific glucose response elements reported elsewhere (29) . Targeted proteomics confirmed by EMSA/supershift assays revealed activation of IRF-1 and CREB, nuclear proteins downstream of JAK-2 and MAPK signaling cascades, in leptin-treated cells. Excluded from this group were TFs such as aryl hydrocarbon receptor (AhR), peroxisome proliferator-activated receptor (PPAR␥), and upstream stimulatory factor (USF), previously shown to be glucose-activated (9, 29) with putative binding sites in the glucose-responsive THBS1 promoter. Although the smooth muscle cell-specific leptin response elements identified in the current study were distinct from endothelial cell-specific glu- cose-response elements reported earlier (9) , the present study revealed some overlapping glucose-and leptin-responsive regulatory motifs specific to VSMCs.
Using pharmacological inhibitors and siRNA gene silencing approaches, we previously showed that JAK-2-, ERK1/2-, and JNK-dependent signaling mediates increased TSP-1 mRNA and protein expression in leptin-treated HASMCs (8) . A growing body of literature indicates that JAK-2 and MAPK activation promotes interaction between multiple TFs, including GAS/ISRE-binding proteins, CREB, NF-B, c-JUN, and acti- . Leptin stimulates cooperative recruitment of IRF-1 and CREB on the THBS1 promoter in HASMCs. Primary HASMC cultures were incubated with or without 100 ng/ml leptin for 3 h, and chromatin was isolated and subjected to chromatin immunoprecipitation (ChIP). ChIP reactions were set up using anti-IRF-1, anti-CREB, or IgG antibody, and the precipitated DNA of the promoter-specific leptin-response elements was amplified using THBS1-specific IRF-1 (A and B), THBS1-specific CREB (C and D), and GAPDH primers as controls (E and F) . A, C, and E: representative PCR blots. B, D, and F: densitometric quantification of PCR blots from 3 independent experiments. Values are means Ϯ SE. *P Յ 0.05 vs. control.
vator protein 1, and a cooperative recruitment of these nuclear proteins to specific regulatory elements on target gene promoters mediates gene transcription (11) . Earlier work demonstrated that glucose-specific upregulation of TSP-1 transcription was mediated via association between several TFs, controlled by cell-specific mechanisms (9, 29, 39) . Specifically, the GAS/ISRE-binding nuclear protein IRF-1 was imperative for induction of TSP-1 transcription in glucose-stimulated VSMCs (29) . GAS/ISRE serves as the common cis-acting element for TFs including Stats and IRFs, triggering activation or repression of the target gene promoter. In the present study, an IRF-1-binding motif distally located on the THBS1 promoter was identified as a key leptin response element required for increased TSP-1 transcription. Besides GAS/ISRE-binding proteins, high glucose was previously shown to activate AhR, a ligand-activated TF responsive to diverse chemically unrelated xenobiotic compounds including 2,3,7,8-tetrachlorodibenzo-p-dioxin and modified LDLs. Specifically, we have shown increased AhR-binding activity to the proximal THBS1 promoter in response to high glucose that was specific to VSMCs driving glucose-induced THBS1 transcription (29) . Contrary to these results, leptin stimulation failed to induce AhR activation in the present study (data not shown), suggesting disparate mechanisms for glucose-and leptin-induced TSP-1 transcription in VSMCs. Importantly, in addition to IRF-1, CREB-binding elements in the distal THBS1 promoter were required for activation of TSP-1 transcription by leptin. Collectively, the present study has revealed an important combinatorial role of the nuclear proteins IRF-1 and CREB in leptin-induced TSP-1 transcription (Fig. 7) . While these data recall earlier reports depicting GAS-and CRE-binding elements in leptin-mediated regulation of the cell cycle and cell proliferation in endometrial cancer (7), these results are in contrast to earlier findings that glucose-induced TSP-1 transcription was dependent on association of IRF-1 with AhR, PPAR, and USF1/2 (29) .
IRF-1, member of the IRF family of TFs, regulates interferon-responsive target genes via interaction with ISRE in the target gene promoter (13) . Numerous studies underscore the importance of IRF-1 in regulatory processes including tumor suppression, apoptosis, cell cycle regulation, and immune responses. While earlier studies have reported that IRF-1 inhibits neointimal growth following vascular injury (40) , an emerging line of evidence supports the notion that IRF-1 modulates inflammatory mediators (2, 42) . Previous studies have demonstrated IRF-1 induction by oxidized LDL in plaque macrophages (14) . More recent reports have indicated IRF-1 as a mediator of IL-8 production in atherosclerosis induced by 25-hydroxycholesterol (38) . Congruent to these reports, the current work highlights the role of IRF-1 as a regulator of leptin-induced TSP-1 transcription in VSMCs.
On the other hand, CREB, a cellular TF, binds to specific DNA sequences modulating the expression of several cAMPresponsive target genes. CREB activation is regulated by numerous extracellular stimuli, including growth factors, cellular stressors, and cytokines (34); dimerization and transcriptional activation of CREB are dependent on phosphorylation via multiple kinases acting at distinct phosphorylation sites, resulting in positive regulation of CREB bioactivity. Increasing evidence indicates regulation of CREB activation via posttranslational modifications and recruitment of specific coactivator proteins, serving as binding partners to CREB (15) . Previous studies have also shown that leptin-induced increase in CREB-binding activity is important for enhanced cyclin D1 expression promoting endometrial cancer cell proliferation (7) . A similar role of CREB has been documented in leptin-induced E-cadherin expression in breast cancer (MCF-7) cells, facilitating primary breast tumorigenesis by leptin (21) . In line with these data, the present study elucidates an important regulatory function of CREB necessary for leptin-induced TSP-1 transcription. Importantly, we have shown that assembly of a single complex between IRF-1 and CREB on the THBS1 promoter regulates increased TSP-1 transcription, specific to leptin. Moreover, both Stat-1 and Stat-3 proteins were identified in this complex, revealed by EMSA/supershift assay, suggesting GAS-element-binding proteins as coactivators of leptin-induced TSP-1 transcription. Interestingly, EMSA/supershift assay also revealed JAK-2 as part of this transcriptional complex recruited to the TSP-1 promoter in response to leptin (Fig. 3) . Contrary to the canonical JAK-2/Stat pathway, where JAK-2, a nonreceptor cytoplasmic tyrosine kinase, regulates activation of multiple signaling pathways, recent studies have reported a nuclear form of JAK-2 that associates with numerous cellular functions, including cell cycle progression and apoptosis (27, 44) . Nuclear JAK-2 via direct interaction with nucleoproteins, including histone H3 at tyrosine 41 (H3Y41), nuclear factor 1-C2 (NF1-C2), and switch sucrose nonfermentable (SWI/SNF)-related helicases/ATPases (RUSH)-1␣, regulates gene expression, independent of Stat proteins (23, 27) . Accordingly, the current findings suggest that JAK-2 is a possible coactivator of the IRF-1-CREB complex in leptin-induced TSP-1 transcription.
Finally, in the present study, leptin-induced activation of the THBS1 promoter was completely abrogated by IRF-1-and CREB-binding decoy oligomers, whereas corresponding mismatched oligomers had no effect. Specifically, in the presence of a large molar excess of decoy oligomers, leptin-activated IRF-1 and CREB revealed a much higher affinity for decoy sequences, which prevented binding of activated nuclear proteins to their putative DNA-binding elements on the THBS1 promoter, attenuating promoter activity in response to leptin. Additionally, leptin failed to activate the THBS1 promoter with mutations affecting core sequences of IRF-1-or CREBbinding motifs, despite the presence of intact CREB or IRF-1 regulatory elements. These data lend strong support to the notion that while both IRF-1 and CREB are imperative for increased TSP-1 transcription by leptin, these regulatory elements are not independently sufficient for leptin-induced TSP-1 gene transcription. Finally, it is worth noting that leptin was used at relatively high pathophysiological levels in the present study. Such high concentrations were used to simulate pathophysiologically relevant hyperleptinemic conditions in Fig. 7 . Proposed model for molecular mechanism of leptininduced TSP-1 transcription. High pathophysiological concentrations of leptin (100 ng/ml) promote formation and recruitment of a single transcriptional complex between the nuclear proteins IRF-1 and CREB on the Ϫ1270/ϩ750 THBS1 promoter, triggering enhanced TSP-1 transcription by leptin in vascular smooth muscle cells. Stat-3 serves as a binding partner of the IRF-1-CREB complex on the THBS1 promoter and displays direct interaction selectively with IRF-1. Arrows denote putative IRF-1-and CREB-binding sites on the distal end of the THBS1 promoter, close to the Ϫ1270 site. our in vitro cell culture system. While we acknowledge limitations that characterize in vitro-to-in vivo correlations, the leptin concentrations used were the minimal optimal levels necessary for an acute in vitro response in HASMCs.
In summary, the present study provides novel evidence that leptin augments cooperative association between IRF-1 and CREB. Notably, assembly and recruitment of a single transcriptional complex between IRF-1 and CREB on the THBS1 promoter provide the molecular basis for leptin-induced TSP-1 gene transcription in HASMCs. While our unpublished observations indicate TSP-1 induction by leptin in bovine aortic endothelial cells, further studies are needed to explore the putative cross talk between leptin and TSP-1 in cells (endothelial cells and macrophages) pertinent to atherosclerotic burden. Future studies dissecting the role of the IRF-1-CREB axis in vivo in regulation of TSP-1 and abnormal VSMC function, specific to leptin, are warranted. Additional studies are also needed to assess the importance of this pathway in cell types pertinent to leptin-induced vascular dysfunction.
